Australasian Society of Clinical Immunology and Allergy Limited (ASCIA) is registered as a Company limited by guarantee (ACN 608 798 241; ABN 45 615 521 452).
The Company Directors are members of the ASCIA Executive: Dr William Smith (ASCIA President), Dr Brynn Wainstein (President Elect), Dr Jan Sinclair and Dr Michael O'Sullivan. The Company Secretary is Jill Smith (ASCIA Chief Executive Officer).
The new constitution for ASCIA is available on this webpage.
Allergy and Immunology Foundation of Australasia (AIFA) is an initiative and branch of ASCIA and is therefore not registered as a separate company.
AIFA was established by ASCIA in 2013 with the main aim to raise funds to support research into disorders of the human immune system in Australia and New Zealand. These disorders comprise allergic diseases, primary immunodeficiencies and other immune diseases.
ASCIA and AIFA are registered with the Australian Charities and Not-for-profits Commission (ACNC) with tax deductible status. ASCIA has been registered as a charity since 2005.
ASCIA was previously registered as an incorporated association No A0021111T with Consumer Affairs Victoria.
Content updated January 2017